BUSINESS

• AZ Japan to Shed 40 Primary Care Jobs Via Voluntary Redundancy
  December 6, 2016

• Novartis Files Tafinlar-Mekinist Combo for NSCLC
  December 6, 2016

• Daiichi Sankyo’s HER2-Targeting ADC Gets Fast-Track Status in US
  December 5, 2016

• Takeda, Lightstone Ventures Set Up Neuroscience R&D Firm
  December 5, 2016

• Shionogi’s Sakigake-Designated Flu Drug Delivers Add’l Favorable PII Data
  December 5, 2016

• Annual Price Revision Could Plunge Pharma Industry into Doldrums: Pfizer Japan Chief
  December 5, 2016

• FDA Accepts sNDA for Abilify Maintena’s Bipolar I Disorder Indication
  December 2, 2016

• Novartis Seeks Aplastic Anemia Indication for Revolade, Neoral
  December 2, 2016

• Takeda to Build Dengue Vaccine Plant in Germany
  December 2, 2016

• JACE for Giant Congenital Melanocytic Nevus Covered by Health Insurance: J-TEC
  December 2, 2016

• Pfizer Japan Completes Transfer of Generics from Hospira Japan
  December 2, 2016

• Oncolys Licenses Oncolytic Virus Telomelysin to Hengrui in China
  December 2, 2016

• Shionogi Files Abuse-Deterrent Painkiller Oxycodone in Japan
  December 1, 2016

• Chugai Seeks Large Vessel Vasculitis Indication for Actemra
  December 1, 2016

• Signs of Growth in Prescribing SGLT-2 Inhibitors with Favorable Environment Change
  November 30, 2016

• Shionogi Says UK Court Finds Its HIV Drug Patent Invalid, Set to Challenge Ruling
  November 29, 2016

• Santen Eyes US Filing for Opsiria Early Next Year
  November 29, 2016

• Chugai Licenses Class I PI3K Inhibitor to German Drug Maker
  November 29, 2016

• Ono to Offer New Invoice Prices for Opdivo Early on to Avoid Distribution Confusion
  November 29, 2016

• Prosecutors Seek 2.5 Years in Jail for Ex-Novartis Employee: Diovan Case
  November 28, 2016

ページ

• « 先頭
• ‹ Prev
• …
• 459
• 460
• 461
• 462
• 463
• 464
• 465
• 466
• 467
• …
• Next ›
• 最終 »